Luria Auditorium, Koch Institute
500 Main Street, Cambridge, MA 02139
Monitoring and Treating Neurological Conditions Through Focal Interfacing with the Brain
Neurological dysregulation serves as the fundamental basis for a spectrum of debilitating disorders such as Parkinson's disease and epilepsy. Despite considerable efforts, our current comprehension of these disorders and ability to treat them remains limited. Neurochemical sampling of the affected tissue can be used to monitor pathological states, but existing tools are limited by tissue reactivity and suboptimal spatiotemporal resolution. Additionally, methods for treating neurological disorders predominantly rely on systemic drug administration which is hampered by inadequate targeting and off-target effects. This thesis introduces a minimally invasive neural implant platform capable of both localized drug infusion and micro-invasive fluid sampling with high spatial precision. These micron-scale devices minimize implantation-induced scarring and support chronic use. We investigated two key questions: (1) Can localized drug delivery to specific neural circuits effectively treat neurological disorders? (2) Can micro-invasive sampling of interstitial brain fluid enable accurate diagnosis and monitoring? We assessed our ability to treat focal epilepsy with this platform by delivering antiseizure medications directly to the seizure focus in a mouse model of temporal lobe epilepsy. We found that localized drug delivery effectively suppressed seizure activity without adverse effects. We also explored micro-invasive, membrane-free sampling of interstitial fluid from different brain regions using our device. We detected hundreds of distinct proteins from minute sample volumes with high spatial resolution and minimal tissue damage. The results from both studies highlight the potential of this dual-function platform for targeted drug delivery and biomarker detection across a variety of disease states.
Thesis Supervisor:
Michael J. Cima, PhD
Professor of Materials Science and Engineering, MIT
Thesis Committee Chair:
Forest M. White, PhD
Professor of Biological Engineering, MIT
Thesis Readers:
Karen S. Wilcox, PhD
Professor and Chair of Pharmacology and Toxicology, University of Utah
John D. Rolston, MD, PhD
Director of Epilepsy Surgery, Brigham and Women's Hospital
Associate Professor of Neurosurgery, Harvard Medical School
________________________________________________________________________________________
Zoom Invitation
Hannah Jackson is inviting you to a scheduled Zoom meeting
Topic: Hannah Jackson MEMP PhD Thesis Defense
Time: Monday, April 28, 2025, 1:00 PM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu (hst[at]mit[dot]edu), at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
https://mit.zoom.us/j/92746174162
Password: 305663
One tap mobile
+16465588656,,92746174162# US (New York)
+16699006833,,92746174162# US (San Jose)
Meeting ID: 927 4617 4162
US: +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/a2c5u1n1v
Join by SIP
92746174162 [at] zoomcrc.com (92746174162[at]zoomcrc[dot]com)
Join by Skype for Business
https://mit.zoom.us/skype/92746174162